Geron reported $-236K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Amgen USD 3.83B 130M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Cassava Sciences USD -11.17M 2.38M Mar/2026
Cytokinetics USD -181.23M 2.86M Mar/2026
Exelixis USD 251.34M 15.43M Mar/2026
Genmab DKK 260M 199M Dec/2025
Geron USD -236K 10.55M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
MacroGenics USD -31.88M 19.79M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Novavax USD 20.94M 100.32M Dec/2025